Display options
Cite
Takatsu H, Scheffel U, Fujiwara H. Sympathetic tone assessed by washout of iodine 125-labeled metaiodobenzylguanidine from the murine left ventricle--influence of immobilization stress and inhibition of the renin-angiotensin system. J Nucl Cardiol. 1995;2(6):507-12doi: 10.1016/s1071-3581(05)80043-1.
Takatsu, H., Scheffel, U., & Fujiwara, H. (1995). Sympathetic tone assessed by washout of iodine 125-labeled metaiodobenzylguanidine from the murine left ventricle--influence of immobilization stress and inhibition of the renin-angiotensin system. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2(6), 507-12. https://doi.org/10.1016/s1071-3581(05)80043-1
Takatsu, H, et al. "Sympathetic tone assessed by washout of iodine 125-labeled metaiodobenzylguanidine from the murine left ventricle--influence of immobilization stress and inhibition of the renin-angiotensin system." Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology vol. 2,6 (1995): 507-12. doi: https://doi.org/10.1016/s1071-3581(05)80043-1
Takatsu H, Scheffel U, Fujiwara H. Sympathetic tone assessed by washout of iodine 125-labeled metaiodobenzylguanidine from the murine left ventricle--influence of immobilization stress and inhibition of the renin-angiotensin system. J Nucl Cardiol. 1995 Nov-Dec;2(6):507-12. doi: 10.1016/s1071-3581(05)80043-1. PMID: 9420833.
Copy Download .nbib Format: NLM
Share it on

J Nucl Cardiol. 1995 Nov-Dec;2(6):507-12. doi: 10.1016/s1071-3581(05)80043-1.

Sympathetic tone assessed by washout of iodine 125-labeled metaiodobenzylguanidine from the murine left ventricle--influence of immobilization stress and inhibition of the renin-angiotensin system.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology

H Takatsu, U Scheffel, H Fujiwara

Affiliations

  1. Second Department of Internal Medicine, Gifu University School of Medicine, Japan.

PMID: 9420833 DOI: 10.1016/s1071-3581(05)80043-1

Abstract

BACKGROUND: Because it is not metabolized as is norepinephrine (NE), most of the metaiodobenzylguanidine (MIBG) taken up by the heart is considered to be lost subsequently by release concomitant with sympathetic stimulation. Therefore we examined whether the washout of MIBG is influenced by sympathetic tone, which we modulated by using immobilization stress or activation of the renin-angiotensin system (RAS).

METHODS AND RESULTS: In 175 male ddY mice, left ventricular radioactivity was counted 30 minutes or 4 hours after injection of 74 kBq (2 microCi) of iodine 125- or iodine 131-labeled MIBG (125I- or 131I-MIBG). The washout rates of MIBG were determined under immobilization stress or under sodium loading or restriction in combination with losartan (10 mg/kg) or cilazapril (1 mg/kg) pretreatment. Immobilization enhanced the washout of 125I-MIBG (80.9% vs 57.9% in the control animals); this was determined to be related to washout from the neuronal compartment, because the nonneuronal component assessed through desipramine pretreatment was not affected. Pretreatment with losartan or cilazapril decreased the facilitation of 125I-MIBG washout in sodium-restricted mice (40.9% and 33.7%, respectively, vs 43.5% in the control animals), but not in sodium-loaded mice.

CONCLUSIONS: Measurement of MIBG washout may be feasible for determining the changes in sympathetic tone caused by immobilization stress or activation of the RAS.

References

  1. Naunyn Schmiedebergs Arch Pharmacol. 1982 Oct;321(1):20-7 - PubMed
  2. J Nucl Med. 1981 Jan;22(1):22-31 - PubMed
  3. Circulation. 1988 Nov;78(5 Pt 1):1192-9 - PubMed
  4. Am J Cardiol. 1984 Oct 1;54(7):783-6 - PubMed
  5. Circ Res. 1975 Dec;37(6):855-62 - PubMed
  6. Lancet. 1992 Nov 14;340(8829):1173-8 - PubMed
  7. Nucl Med Commun. 1988 Sep;9(9):663-7 - PubMed
  8. Circulation. 1993 May;87(5 Suppl):IV7-13 - PubMed
  9. N Engl J Med. 1987 Jun 4;316(23 ):1429-35 - PubMed
  10. J Nucl Med. 1986 Jan;27(1):84-9 - PubMed
  11. Br J Pharmacol. 1971 Feb;41(2):239-55 - PubMed
  12. Eur J Pharmacol. 1980 Nov 21;68(2):209-12 - PubMed
  13. J Pharmacol Exp Ther. 1990 Feb;252(2):711-8 - PubMed
  14. Circulation. 1993 Jul;88(1):136-45 - PubMed
  15. J Nucl Med. 1993 Apr;34(4):589-600 - PubMed
  16. Am J Cardiol. 1992 Oct 8;70(10):113C-118C - PubMed
  17. J Nucl Med. 1992 Aug;33(8):1444-50 - PubMed
  18. Circulation. 1993 May;87(5 Suppl):IV90-6 - PubMed
  19. J Nucl Med. 1992 Apr;33(4):471-7 - PubMed
  20. Naunyn Schmiedebergs Arch Pharmacol. 1991 Sep;344(3):297-301 - PubMed
  21. Fed Proc. 1972 Jul-Aug;31(4):1351-7 - PubMed
  22. J Nucl Med. 1987 Oct;28(10 ):1620-4 - PubMed
  23. Circulation. 1978 Nov;58(5):763-70 - PubMed
  24. Circulation. 1990 Nov;82(5):1724-9 - PubMed
  25. Cancer Res. 1987 Aug 1;47(15):3920-8 - PubMed

Substances

MeSH terms

Publication Types